Detalhe da pesquisa
1.
A Bispecific, Tetravalent Antibody Targeting Inflammatory and Pruritogenic Pathways in Atopic Dermatitis.
JID Innov;
4(2): 100258, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38375189
2.
Effect of inhaled KP-496, a novel dual antagonist of the cysteinyl leukotriene and thromboxane A2 receptors, on a bleomycin-induced pulmonary fibrosis model in mice.
Pulm Pharmacol Ther;
23(5): 425-31, 2010 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20457270
3.
Establishment of a system to evaluate the therapeutic effect and the dynamics of an investigational drug on ulcerative colitis using human colonic organoids.
J Gastroenterol;
54(7): 608-620, 2019 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30599053
4.
Oral administration of EP4-selective agonist KAG-308 suppresses mouse knee osteoarthritis development through reduction of chondrocyte hypertrophy and TNF secretion.
Sci Rep;
9(1): 20329, 2019 12 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31889132
5.
KAG-308, a newly-identified EP4-selective agonist shows efficacy for treating ulcerative colitis and can bring about lower risk of colorectal carcinogenesis by oral administration.
Eur J Pharmacol;
754: 179-89, 2015 May 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25704618
6.
KIF1Bbeta2, capable of interacting with CHP, is localized to synaptic vesicles.
J Biochem;
132(3): 483-91, 2002 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12204119